Pubblicazioni

Timing and deepness of response to tyrosine kinase inhibitors as a measure of potential treatment discontinuation in chronic myeloid leukemia patients managed in the real-life

2017 - AMERICAN JOURNAL OF HEMATOLOGY
Breccia, Massimo; Colafigli, Gioia; Molica, Matteo; Scalzulli, Emilia; Diverio, Daniela; Latagliata, Roberto; Guarini, Anna; Foà, Robin

Correlation between Charlson comorbidity index and outcome in patients with chronic phase chronic myeloid leukemia treated with second-generation tyrosine kinase inhibitors upfront

2015 - LEUKEMIA & LYMPHOMA
Breccia, M; Molica, Matteo; Colafigli, Gioia; Zacheo, I; Latagliata, Angelo Raffaele; Tafuri, Agostino; Alimena, Giuliana

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma